These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9884874)

  • 21. Once versus thrice daily tobramycin alone and in combination with ceftazidime, ciprofloxacin and imipenem in an in vitro pharmacodynamic model.
    Zelenitsky SA; Karlowsky JA; Hoban DJ; Kabani A; Zhanel GG
    Chemotherapy; 1998; 44(1):1-6. PubMed ID: 9444401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypotension associated with intravenous haloperidol and imipenem.
    Franco-Bronson K; Gajwani P
    J Clin Psychopharmacol; 1999 Oct; 19(5):480-1. PubMed ID: 10505596
    [No Abstract]   [Full Text] [Related]  

  • 23. [Why meropenem and not imipenem?].
    Fuursted K; Møller JK
    Ugeskr Laeger; 2003 Mar; 165(10):1046-7; author reply 1047. PubMed ID: 12645417
    [No Abstract]   [Full Text] [Related]  

  • 24. The relationship between the daily dosage of the carbapenem meropenem (MEPM) and MEPM-resistant Pseudomonas aeruginosa.
    Harashima S; Kondo H; Nabeshima A; Shimoda M; Yamaji K; Horiuchi T; Shimono N; Ikematsu H
    J Infect Chemother; 2008 Jun; 14(3):219-22. PubMed ID: 18574658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.
    Nichols RL; Smith JW; Geckler RW; Wilson SE
    South Med J; 1995 Apr; 88(4):397-404. PubMed ID: 7716590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of early continuous regional arterial infusion of protease inhibitor and antibiotic in nonsurgical treatment of acute necrotizing pancreatitis.
    Takeda K; Sunamura M; Shibuya K; Kobari M; Matsuno S
    Digestion; 1999; 60 Suppl 1():9-13. PubMed ID: 10026424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of obstetric and gynecologic infections with meropenem: comparison with imipenem/cilastatin.
    Maggioni P; Di Stefano F; Facchini V; Irato S; Mancuso S; Colombo M; Massobrio M; Melis GB; Crosignani P
    J Chemother; 1998 Apr; 10(2):114-21. PubMed ID: 9603636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Penetration of imipenem/cilastatin sodium into the tissues of the female reproductive organs].
    Maeda Y; Sengoku K; Mure K; Yamashita K; Shimizu T
    Jpn J Antibiot; 1986 May; 39(5):1337-41. PubMed ID: 3463779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imipenem.
    Locham KK; Sodhi M; Sarwal D
    Indian Pediatr; 2002 Jul; 39(7):703; author reply 703-4. PubMed ID: 12147908
    [No Abstract]   [Full Text] [Related]  

  • 30. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
    Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T
    J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis.
    Novelli A; Adembri C; Livi P; Fallani S; Mazzei T; De Gaudio AR
    Clin Pharmacokinet; 2005; 44(5):539-49. PubMed ID: 15871639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis.
    Takeda K; Matsuno S; Sunamura M; Kakugawa Y
    Am J Surg; 1996 Apr; 171(4):394-8. PubMed ID: 8604829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imipenem/cilastatin as empirical treatment of severe infections in compromised patients.
    Biglino A; Bonasso M; Gioannini P
    J Chemother; 1991 Jan; 3 Suppl 1():208-12. PubMed ID: 12041767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of imipenem in healthy volunteers following administration by 2 h or 0.5 h infusion.
    Jaruratanasirikul S; Raungsri N; Punyo J; Sriwiriyajan S
    J Antimicrob Chemother; 2005 Dec; 56(6):1163-5. PubMed ID: 16234333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of imipenem in critically ill patients during empirical treatment of nosocomial pneumonia: a comparison of 0.5-h and 3-h infusions.
    Lipš M; Siller M; Strojil J; Urbánek K; Balík M; Suchánková H
    Int J Antimicrob Agents; 2014 Oct; 44(4):358-62. PubMed ID: 25216543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Meropenem (Merrem) vs imipenem/cilastatin in hospital treatment of intra-abdominal infections. A multicenter study].
    Tonelli F
    Minerva Chir; 1997 Mar; 52(3):317-26. PubMed ID: 9148225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fundamental and clinical studies with imipenem/cilastatin sodium, a new carbapenem antibiotic, in the field of pediatrics].
    Nakazawa S; Sato H; Narita A; Matsumoto K; Suzuki H; Nakazawa S; Chikaoka H; Koido R; Kamigaki M; Nakada Y
    Jpn J Antibiot; 1986 Jul; 39(7):1745-64. PubMed ID: 3464777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program.
    Ong CT; Kuti JL; Nicolau DP;
    Surg Infect (Larchmt); 2005; 6(4):419-26. PubMed ID: 16433606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacokinetic and clinical studies of imipenem/cilastatin sodium in the pediatric field].
    Motohiro T; Koga T; Shimada Y; Tomita S; Fujimoto T; Nishiyama T; Tominaga K; Yamashita F; Suzuki K; Toyoda O
    Jpn J Antibiot; 1986 Jul; 39(7):1889-911. PubMed ID: 3464784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Concentration of imipenem/cilastatin sodium in bone marrow blood following intravenous drip infusion].
    Ojima T; Ohira N; Sakurai M
    Jpn J Antibiot; 1986 Jul; 39(7):1938-46. PubMed ID: 3464786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.